DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-82 Cr | ₹-83 Cr | ₹-42 Cr | ₹-37 Cr | ₹-33 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR LAL PATHLABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-82 Cr |
| Mar2025 | ₹-83 Cr |
| Mar2024 | ₹-42 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-33 Cr |
How is Deferred Tax Assets / Liabilities of DR LAL PATHLABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-82 Cr | Negative | |
| Mar2025 | ₹-83 Cr | Negative | |
| Mar2024 | ₹-42 Cr | Negative | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-33 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹29,064.4 Cr | 2.4% | 5.7% | 16.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹127,771.0 Cr | 0.5% | 5.9% | 19.7% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹106,929.0 Cr | -0.9% | 7.3% | -11.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹72,736.4 Cr | -0.5% | -0.6% | 24.4% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹70,731.9 Cr | 0.4% | 4.1% | 35.2% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹41,493.4 Cr | 0.2% | 9% | 3.6% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 2.4% |
5.7% |
16.3% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses